New Zealand markets closed

CVS Health Corporation (CVS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
56.31-11.40 (-16.84%)
At close: 04:00PM EDT
56.79 +0.48 (+0.85%)
Pre-market: 06:21AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 70.69B
Enterprise value 139.39B
Trailing P/E 9.88
Forward P/E 6.78
PEG ratio (5-yr expected) 0.82
Price/sales (ttm)0.20
Price/book (mrq)0.96
Enterprise value/revenue 0.39
Enterprise value/EBITDA 7.66

Trading information

Stock price history

Beta (5Y monthly) 0.51
52-week change 3-18.14%
S&P500 52-week change 323.57%
52-week high 383.25
52-week low 354.00
50-day moving average 373.58
200-day moving average 372.58

Share statistics

Avg vol (3-month) 310.3M
Avg vol (10-day) 314.17M
Shares outstanding 51.26B
Implied shares outstanding 61.26B
Float 81.25B
% held by insiders 10.12%
% held by institutions 182.53%
Shares short (15 Apr 2024) 418M
Short ratio (15 Apr 2024) 41.93
Short % of float (15 Apr 2024) 41.43%
Short % of shares outstanding (15 Apr 2024) 41.43%
Shares short (prior month 15 Mar 2024) 418.64M

Dividends & splits

Forward annual dividend rate 42.66
Forward annual dividend yield 44.72%
Trailing annual dividend rate 32.48
Trailing annual dividend yield 33.66%
5-year average dividend yield 42.86
Payout ratio 443.51%
Dividend date 301 May 2024
Ex-dividend date 419 Apr 2024
Last split factor 22:1
Last split date 307 Jun 2005

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 2.04%
Operating margin (ttm)2.07%

Management effectiveness

Return on assets (ttm)3.18%
Return on equity (ttm)10.09%

Income statement

Revenue (ttm)359.66B
Revenue per share (ttm)281.15
Quarterly revenue growth (yoy)3.60%
Gross profit (ttm)N/A
EBITDA 16.93B
Net income avi to common (ttm)7.32B
Diluted EPS (ttm)5.70
Quarterly earnings growth (yoy)-47.90%

Balance sheet

Total cash (mrq)13.09B
Total cash per share (mrq)10.43
Total debt (mrq)81.79B
Total debt/equity (mrq)110.31%
Current ratio (mrq)0.81
Book value per share (mrq)59.08

Cash flow statement

Operating cash flow (ttm)10.89B
Levered free cash flow (ttm)8.37B